GSK confirmed this morning that the disappointing readout from the DREAMM-3 trial of multiple myeloma therapy Blenrep reported earlier this month means that it will take the drug off the US market ...

Belantamab mafodotin is under clinical development by GSK and currently in Phase I for Systemic Lupus Erythematosus.

GSK's BCMA-directed antibody-drug conjugate Blenrep reduced the risk of death by 42% in a multiple myeloma trial that the company believes could be practice-changing. The DREAMM-7 study showed ...

On Friday, the China National Medical Products Administration approved GSK plc (NYSE:GSK) Nucala (mepolizumab) as an add-on ...

Also Read: GSK Raises Prospects For Withdrawn Blood Cancer Drug Blenrep To Return To US Market – Here's Why People with CRSwNP experience symptoms such as nasal obstruction, loss of smell ...

A New York appellate court on Tuesday denied President-elect Donald Trump's bid to halt sentencing set for Friday for his conviction on criminal charges stemming from hush money paid to a porn ...

Ukraine's air force says one of its F-16 fighter jet pilots shot down six missiles during a Russian aerial attack last month. Meanwhile, Moscow says its troops have inflicted a series of defeats ...

Israel’s genocide in Gaza has put at least 114 hospitals and clinics out of service, yet nurses and doctors vow to continue providing care under the worst conditions imaginable. Fury at the ...

Dec. 19, 2024 — New research shows that three sites spread along an approximately 620-mile portion of today's Denali Fault were once a smaller united geologic feature indicative of the final ...

Jan. 6, 2025 — New research shows that the sweeping land use changes and irrigation of the U.S. Corn Belt, along with the influence of the area's shallow ... Floods Linked to Rise in US Deaths ...

Justin Trudeau announced Monday that he was also stepping down as leader of Canada’s Liberal Party. He will remain in both roles until a replacement is chosen. By Matina Stevis-GridneffIan ...

Russia and other hostile states have become increasingly brazen in adopting “gray zone” attacks against Europe and the United States, leaving defense officials with a dilemma: How to respond ...